H. Lundbeck A/S
Bywater Consulting Group
Healthcare Businesswomen's Association (HBA)
MSD, Montes Claros, MG, Brazil
Biotechnology Innovation Organization
Janssen Supply Chain
Life Science Leader
Ferring Pharmaceutical, Inc.
Life Science Leader
MedImmune / AstraZeneca
IN THIS MONTH'S ISSUE
From Academia to Industry – How Biopharma Entrepreneurship Became A Calling6/1/2021
While I knew that I wanted to dedicate my life to developing gene therapies to cure human diseases, I could not have predicted that I would leave academia to become an entrepreneur.
How To Identify Capital To Fund Life Sciences Growth6/1/2021
For life sciences companies, funding needs evolve at every stage of growth — creating both challenges and opportunities. Regardless of the stage, it is fundamental to align your funding strategy with your company’s vision.
Don’t Overlook The Risks Of Innovative Clinical Trials6/1/2021
Advancements in AI and machine learning (ML) for data collection and interpretation could increase the threat of cyber-attacks and malicious hacking of private medical data. As such, sponsors shouldn’t overlook the liability risk of such advancements and the corresponding changes that should be made to business insurance.
Readying For Commercialization6/1/2021
Commercialization planning is particularly important in today’s continuously evolving biopharma marketplace. Not only do you have to manage and allocate capital appropriately but also manage and mitigate the inherent risks in the process — to the extent possible.
BEYOND THE PRINTED PAGE
International Conference on Sensors and Electronic Instrumentation
June 14 - 15, 2021
EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution Webinar
June 29, 2021
Auditing Laboratories Conducting Assays Supporting Biologics
July 2, 2021
Importing and Exporting Covid-19 Products
July 5, 2021
The Most Common Problems in FDA Software Validation & Verification
July 7, 2021